您的位置: 首页 > 农业专利 > 详情页

DERIVADOS DE 2-(2,4,5-ANILINO-SUBSTITUÍDOS)PIRIMIDINA COMO MODULADORES DO EGFR ÚTEIS PARA O TRATAMENTO DO CANCRO
专利权人:
ASTRAZENECA AB
发明人:
申请号:
PT17194307
公开号:
PT3333161T
申请日:
2012.07.25
申请国别(地区):
PT
年份:
2020
代理人:
摘要:
The present invention relates to certain 2-(2,4,5-substituted-anilino)pyrimidine compounds and pharmaceutically acceptable salts thereof which may be useful in the treatment or prevention of a disease or medical condition mediated through certain mutated forms of epidermal growth factor receptor (for example the L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant). Such compounds and salts thereof may be useful in the treatment or prevention of a number of different cancers. The invention also relates to pharmaceutical compositions comprising said compounds and salts thereof, especially useful polymorphic forms of these compounds and salts, intermediates useful in the manufacture of said compounds and to methods of treatment of diseases mediated by various different forms of EGFR using said compounds and salts thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充